euro adhoc: DocCheck AG / quarterly or semiannual financial statement / DocCheck has achieved an increase in sales of 15 % in the 2nd quarter

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

6-month report

06.08.2007

Cologne, 6 August 2007 - In the 2nd quarter of 2007 DocCheck AG,
Cologne, (ISIN DE0005471007 //Symbol 547100) has achieved sales
totalling 3.5 million euro. This corresponds to an increase of 15 per
cent when compared to the 2nd quarter of 2006 (3.0 million euro). The
operating result turned out to be negative (- 106 thousand euro) and
fell below the result for the same period in the previous year (+ 87
thousand euro). The result per share is 0 cent (previous year: 2
cent). Overall DocCheck AG's sales have increased by 10 per cent in
the first six months of 2007, rising from 6.2 million euro to 6.8
million euro. Earnings before interest and taxes (EBIT) total - 67
thousand euro (previous year: 415 thousand euro), profit per share is
1 cent (previous year: 7 cent). Liquid funds and current-asset
securities amounted to 14.9 million euro at the end of the 2nd
quarter or 2.53 euro per share (previous year: 16.0 million euro or
2.70 euro per share), due, amongst other things, to the payment of
dividends on 28/06/2007 totalling 570 thousand euro, share buy-backs
(272 thousand euro) and investments in additional office space (300
thousand euro). The 2nd quarter for the DocCheck Group was marked by
a dynamic increase in the portal and trading business on the one hand
and lower customer budgets in the agency business on the other hand.
As already announced at publication of the 1st quarter´s results,
some customers had reduced their marketing expenditure at the
beginning of the year as a result of the changes to the prevailing
statutory conditions caused by major health care reforms and the
ensuing slight decline in the pharmaceutical market. As expected,
sales in the agency business (antwerpes + partner) subsequently
dropped by 3 per cent to 1.3 million euro in the 2nd quarter. The
portal business continued to increase at a rapid pace in terms of
development and investments and sales increased by 15 per cent to 0.8
million euro. Development in the 2nd quarter concentrated on the
development of DocCheck-Faces, a social network software package for
doctors which will appear in its final version as DocCheck-Service
during the 3rd quarter. Sales in the trading business (DocCheck Shop)
increased by 49 per cent to 1.5 million euro. The outlook for the 3rd
quarter is positive. At the beginning of the 3rd quarter incoming
orders in the agency business increased sharply, as reflected in the
orders on the books. In particular the demand for integrated concepts
in e-marketing, Print and PR has increased and a number of new
budgets have been acquired. At the same time the portal and trading
business is developing according to plan. Due to the healthy business
outlook, the board of directors is expecting a positive operating
result for the 3rd quarter with an increase in sales.

end of announcement euro adhoc 06.08.2007 22:00:00
--------------------------------------------------------------------------------

ots Originaltext: DocCheck AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Tanja Mumme
+49 (0)221 92053 139
tanja.mumme@doccheck.com

Branche: Computing & Information Technology
ISIN: DE0005471007
WKN: 547100
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade